Published in J Neurosurg on March 01, 2007
Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics (2017) 0.75
Caspase-3 and survivin expression in primary atypical and malignant meningiomas. ISRN Neurosci (2013) 0.75
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol (2010) 14.79
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood (2010) 3.99
The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res (2007) 2.82
Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res (2008) 2.81
Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood (2009) 2.61
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma. J Clin Oncol (2010) 2.45
Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int (2013) 2.12
Neoplastic meningitis. J Support Oncol (2011) 2.12
Central nervous system cancers. J Natl Compr Canc Netw (2013) 1.82
Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo. Cancer Biol Ther (2005) 1.68
Compliance and efficacy of titratable thermoplastic versus custom mandibular advancement devices. Otolaryngol Head Neck Surg (2012) 1.68
Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines. Cancer Biol Ther (2004) 1.65
Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells. Mol Cancer Res (2008) 1.58
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol (2011) 1.53
Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol (2007) 1.52
Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion. J Leukoc Biol (2007) 1.47
A simple method for isolation and characterization of mouse brain microvascular endothelial cells. J Neurosci Methods (2003) 1.44
Clinical trial end points for high-grade glioma: the evolving landscape. Neuro Oncol (2011) 1.42
Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib. Mol Cancer Ther (2007) 1.41
Mechanisms of disease: temozolomide and glioblastoma--look to the future. Nat Clin Pract Oncol (2008) 1.40
A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res (2011) 1.40
Primary intraosseous meningioma. Neurosurg Focus (2007) 1.39
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas. Cancer (2010) 1.35
HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress. Cancer Res (2007) 1.30
Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurg Focus (2007) 1.29
Pseudoprogression: relevance with respect to treatment of high-grade gliomas. Curr Treat Options Oncol (2011) 1.28
Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma. Mol Ther (2005) 1.25
Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells. Cancer Res (2006) 1.24
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. Neuro Oncol (2008) 1.23
O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems. Biochim Biophys Acta (2012) 1.22
Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One (2012) 1.18
EphB4 provides survival advantage to squamous cell carcinoma of the head and neck. Int J Cancer (2006) 1.18
Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms. Neurosurg Focus (2011) 1.15
Bevacizumab plus irinotecan in recurrent glioblastoma. J Clin Oncol (2008) 1.15
Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. Cancer Res (2008) 1.15
Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs. Expert Opin Investig Drugs (2008) 1.15
Central nervous system cancers. J Natl Compr Canc Netw (2011) 1.13
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma. Neuro Oncol (2010) 1.13
Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors. Hum Gene Ther (2003) 1.12
Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex. Cancer Res (2008) 1.10
Brainstem glioma: a review. Curr Neurol Neurosci Rep (2013) 1.10
Increased expression of TATA-binding protein, the central transcription factor, can contribute to oncogenesis. Mol Cell Biol (2003) 1.09
COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro. Mol Cancer (2008) 1.09
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma. Neurology (2015) 1.08
Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis. Cancer (2010) 1.08
The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells. Cancer Biol Ther (2002) 1.07
Radiation necrosis: relevance with respect to treatment of primary and secondary brain tumors. Curr Neurol Neurosci Rep (2012) 1.06
Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer Lett (2012) 1.04
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo. Mol Cancer (2006) 1.03
Gender disparity in the rate of partner abandonment in patients with serious medical illness. Cancer (2009) 1.03
Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells. Neurosurgery (2009) 1.00
Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model. Neurosurg Focus (2006) 0.99
Adult primary spinal cord tumors. Expert Rev Neurother (2009) 0.99
Does quality of life supplant survival in patients with brain metastasis? J Clin Oncol (2013) 0.99
Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme. Neurosurg Focus (2006) 0.97
Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells. Cancer Res (2005) 0.97
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy. Neurology (2006) 0.96
Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib. Blood (2005) 0.95
Combining aminocyanine dyes with polyamide dendrons: a promising strategy for imaging in the near-infrared region. Chemistry (2011) 0.95
Celecoxib transiently inhibits cellular protein synthesis. Biochem Pharmacol (2007) 0.94
Pseudoprogression in glioblastoma. J Clin Oncol (2008) 0.94
CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2. Exp Neurol (2005) 0.93
Construction of a well-defined multifunctional dendrimer for theranostics. Org Lett (2011) 0.93
Effect of reproductive hormones on ovarian epithelial tumors: I. Effect on cell cycle activity. Cancer Biol Ther (2002) 0.92
Tissue expression of inducible nitric oxide synthase requires IFN-gamma production by infiltrating splenic T cells: more evidence for immunosuppression by nitric oxide. J Neuroimmunol (2003) 0.92
Initial treatment patterns over time for anaplastic oligodendroglial tumors. Neuro Oncol (2012) 0.92
Extra-cellular superoxide promotes T cell expansion through inactivation of nitric oxide. J Neuroimmunol (2004) 0.92
Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent. Pathophysiol Haemost Thromb (2005) 0.92
Noscapine inhibits tumor growth in TMZ-resistant gliomas. Cancer Lett (2011) 0.91
Increased survivin expression confers chemoresistance to tumor-associated endothelial cells. Am J Pathol (2008) 0.91
Glioma-associated endothelial cells show evidence of replicative senescence. Exp Cell Res (2007) 0.91